68Ga-DOTA-BP1

N/A

Report date: 2025/11/20 16:02:53
NME

Base Information

Drug Name68Ga-DOTA-BP1
Drug Alias Name[68Ga]Ga-DOTA-BP1
ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionB-cell maturation protein binders
TargetsB-cell maturation protein
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesThe First Affiliated Hospital Of Beijing University
China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital Of Beijing University
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A